Vanguard Group Portfolio holdings
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.18B |
| 2 |
Medtronic
MDT
|
+$2.06B |
| 3 |
Microsoft
MSFT
|
+$1.61B |
| 4 |
Procter & Gamble
PG
|
+$1.47B |
| 5 |
UBS Group
UBS
|
+$1.01B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.42B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$2.34B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$930M |
| 4 |
Apple
AAPL
|
+$637M |
| 5 |
SWY
SAFEWAY INC
SWY
|
+$620M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.67% |
| 2 | Technology | 13.6% |
| 3 | Financials | 13.57% |
| 4 | Industrials | 10.71% |
| 5 | Consumer Discretionary | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLBH
3626
DELISTED
Carolina Bank Holdings Inc
CLBH
| $1.02M | ﹤0.01% |
102,607
+300
| +0.3% | +$2.87K |
|
|
CRDS
3627
DELISTED
Crossroads Systems, Inc.
CRDS
| $1.01M | ﹤0.01% |
19,979
+1,172
| +6% | +$60.1K |
|
3628
Aspen Aerogels
ASPN
$546M
| $1.01M | ﹤0.01% |
139,019
+12,180
| +10% | +$92.2K |
|
|
SYUT
3629
DELISTED
Synutra International, Inc.
SYUT
| $1.01M | ﹤0.01% |
157,867
+2,453
| +2% | +$13.8K |
|
|
MPO
3630
DELISTED
MIDSTATES PETE CO INC COM NEW
MPO
| $1.01M | ﹤0.01% |
118,412
-39,277
| -25% | -$443K |
|
3631
Achieve Life Sciences
ACHV
$671M
| $1M | ﹤0.01% |
212
+21
| +11% | +$103K |
|
3632
Anterix
ATEX
$1.98B
| $990K | ﹤0.01% |
+19,799
| New | +$962K |
|
3633
Northeast Bank
NBN
$1.14B
| $984K | ﹤0.01% |
106,628
+3,100
| +3% | +$28.9K |
|
3634
InfuSystem Holdings
INFU
$239M
| $983K | ﹤0.01% |
362,678
+3,000
| +0.8% | +$8.12K |
|
|
VRS
3635
DELISTED
VERSO CORP COM STK (DE)
VRS
| $982K | ﹤0.01% |
545,856
-11,464
| -2% | -$27.7K |
|
3636
Smith Micro Software
SMSI
$15.7M
| $981K | ﹤0.01% |
4,791
+626
| +15% | +$144K |
|
3637
Kamada
KMDA
$411M
| $975K | ﹤0.01% |
+220,528
| New | +$947K |
|
3638
Axogen
AXGN
$2.38B
| $974K | ﹤0.01% |
278,297
+112,790
| +68% | +$388K |
|
3639
Citizens Community Bancorp
CZWI
$209M
| $970K | ﹤0.01% |
104,495
+300
| +0.3% | +$2.75K |
|
3640
AerCap
AER
$24.3B
| $962K | ﹤0.01% |
22,042
+1,078
| +5% | +$45.5K |
|
|
FBMS
3641
DELISTED
The First Bancshares, Inc.
FBMS
| $958K | ﹤0.01% |
59,850
+1,800
| +3% | +$26.9K |
|
3642
Data I/O
DAIO
$31.3M
| $957K | ﹤0.01% |
258,609
+2,200
| +0.9% | +$7.25K |
|
3643
Vanguard Financials ETF
VFH
$13.7B
| $956K | ﹤0.01% |
19,399
+4,625
| +31% | +$226K |
|
|
AVGR
3644
DELISTED
Avinger, Inc. Common Stock
AVGR
| $954K | ﹤0.01% |
+1
| New | +$1.38M |
|
|
GFA
3645
DELISTED
Gafisa S.A.
GFA
| $944K | ﹤0.01% |
53,044
+6,111
| +13% | +$113K |
|
|
HMNF
3646
DELISTED
HMN Financial Inc
HMNF
| $941K | ﹤0.01% |
77,432
| – | – |
|
3647
Stereotaxis
STXS
$136M
| $934K | ﹤0.01% |
566,399
+22,059
| +4% | +$35.2K |
|
3648
Apyx Medical
APYX
$179M
| $931K | ﹤0.01% |
389,556
+2,100
| +0.5% | +$6.98K |
|
|
DMK
3649
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
| $931K | ﹤0.01% |
3,375
+2,518
| +294% | +$1.09M |
|
|
DZSI
3650
DELISTED
DZS Inc. Common Stock
DZSI
| $929K | ﹤0.01% |
142,833
+1,606
| +1% | +$11.4K |
|
Similar funds
Vanguard Group's Q1 2015 Portfolio in Review
As of Q1 2015, Vanguard Group held 4,228 positions worth $1.47T, up 6.2% from $1.39T the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Vanguard Group deployed $66B of net new capital in Q1 2015, opening 181 new positions and adding to 3,456 existing holdings. Its largest new stake was UBS Group: 57,940,325 shares worth $1.09B.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $637M trimmed.
- Vanguard Group's largest Q1 2015 buy was UBS Group: 57,940,325 shares worth $1.09B.
- Vanguard Group added most to Allergan plc in Q1 2015, an estimated $2.18B increase.
- Vanguard Group's biggest Q1 2015 reduction was Apple, cutting an estimated $637M.
- Vanguard Group fully exited Allergan Inc in Q1 2015, selling an estimated $3.42B.
- Vanguard Group's ten largest holdings make up 12% of its $1.47T portfolio in Q1 2015.
- Vanguard Group opened 181 new positions and closed 75 in Q1 2015.
- Vanguard Group's portfolio value rose 6.2% quarter-over-quarter to $1.47T.
Based on Vanguard Group's 13F filing for Q1 2015, filed 14 May 2015.